Patents by Inventor John Dodgson
John Dodgson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220133905Abstract: The disclosure provides, methods for preparing scavenging particles, as well as methods for attaching capture agents to the particles. The disclosure further provides compositions that bind to and inhibit the biological activity of soluble biomolecules, as well as pharmaceutical compositions thereof. The compositions may comprise a plurality of particles that specifically bind a target, such as a soluble biomolecule or a biomolecule on the surface of a pathogen, to inhibit the target (or pathogen) from interacting with other molecules or cells. Also provided herein are a number of applications (e.g., therapeutic applications) in which the compositions are useful.Type: ApplicationFiled: June 10, 2021Publication date: May 5, 2022Inventors: Louis Hawthorne, John Dodgson
-
Patent number: 11065345Abstract: The disclosure provides, methods for preparing scavenging particles, as well as methods for attaching capture agents to the particles. The disclosure further provides compositions that bind to and inhibit the biological activity of soluble biomolecules, as well as pharmaceutical compositions thereof. The compositions may comprise a plurality of particles that specifically bind a target, such as a soluble biomolecule or a biomolecule on the surface of a pathogen, to inhibit the target (or pathogen) from interacting with other molecules or cells. Also provided herein are a number of applications (e.g., therapeutic applications) in which the compositions are useful.Type: GrantFiled: January 4, 2018Date of Patent: July 20, 2021Assignee: NaNotics, LLCInventors: Louis Hawthorne, John Dodgson
-
Publication number: 20200179531Abstract: The disclosure provides, methods for preparing scavenging particles, as well as methods for attaching capture agents to the particles. The disclosure further provides compositions that bind to and inhibit the biological activity of soluble biomolecules, as well as pharmaceutical compositions thereof. The compositions may comprise a plurality of particles that specifically bind a target, such as a soluble biomolecule or a biomolecule on the surface of a pathogen, to inhibit the target (or pathogen) from interacting with other molecules or cells. Also provided herein are a number of applications (e.g., therapeutic applications) in which the compositions are useful.Type: ApplicationFiled: January 4, 2018Publication date: June 11, 2020Inventors: Louis Hawthorne, John Dodgson
-
Patent number: 10653790Abstract: The disclosure provides, among other things, compositions that bind to and inhibit the biological activity of soluble biomolecules, as well as pharmaceutical compositions thereof. The compositions may comprise a plurality of particles that specifically bind a target, such as a soluble biomolecule or a biomolecule on the surface of a pathogen, to inhibit the target (or pathogen) from interacting with other molecules or cells.Type: GrantFiled: July 29, 2016Date of Patent: May 19, 2020Assignee: NaNotics, LLCInventors: John Dodgson, Louis Hawthorne
-
Publication number: 20180256747Abstract: The disclosure provides, among other things, compositions that bind to and inhibit the biological activity of soluble biomolecules, as well as pharmaceutical compositions thereof. The compositions may comprise a plurality of particles that specifically bind a target, such as a soluble biomolecule or a biomolecule on the surface of a pathogen, to inhibit the target (or pathogen) from interacting with other molecules or cells. Also provided herein are a number of applications (e.g., therapeutic applications) in which the compositions are useful.Type: ApplicationFiled: June 29, 2016Publication date: September 13, 2018Inventors: Louis Hawthorne, John Dodgson
-
Publication number: 20180214566Abstract: The disclosure provides, among other things, compositions that bind to and inhibit the biological activity of soluble biomolecules, as well as pharmaceutical compositions thereof. The compositions may comprise a plurality of particles that specifically bind a target, such as a soluble biomolecule or a biomolecule on the surface of a pathogen, to inhibit the target (or pathogen) from interacting with other molecules or cells.Type: ApplicationFiled: July 29, 2016Publication date: August 2, 2018Inventors: John Dodgson, Louis Hawthorne
-
Publication number: 20160251628Abstract: The present invention provides devices suitable for filtration including diafiltration of a suspension containing a species such as particles, cells or macromolecules, apparatus comprising such devices and methods of using the devices and apparatus. The devices of the invention comprise a vessel having a filter that divides the vessel into a first chamber and a second chamber provided with various outlet ports. Gas is used to finally concentrate the suspension (118) in the filtration chamber by displacing the liquid up to 95% through the filter (14).Type: ApplicationFiled: October 30, 2014Publication date: September 1, 2016Inventors: John Vincent, Rui Tostoes, Farlan Veraitch, John Dodgson
-
Publication number: 20160243502Abstract: The present invention provides devices, apparatus and systems suitable for achieving volume reduction in a liquid containing a species in suspension and methods of use thereof. The apparatus of the invention comprises (i) a filter device comprising: a tubular first chamber having a filter provided in a surface thereof, a second chamber in fluid communication with the first chamber through the filter, the device being provided with an inlet port opening to the first end of the first chamber, an outlet port opening to the second end of the first chamber, and a filtrate port opening to the second chamber, and (ii) a fluidic pathway from the outlet port, wherein the apparatus is configured to introduce the first liquid and a second fluid immiscible with the first to the first chamber and the apparatus comprises a flow cut-off means in the fluidic pathway from the outlet port.Type: ApplicationFiled: October 30, 2014Publication date: August 25, 2016Inventors: John Vincent, Rui Tostoes, Farlan Veraitch, John Dodgson
-
Publication number: 20070264705Abstract: Apparatus for handling cellular entities comprises a first substrate having an array of first wells open to a first major surface of the first substrate, said first wells being adapted to hold a cellular entity, the apparatus further comprises fluidic channels open to each well. The wells are tapered to locate the cellular entity at a given location in each well, and the fluidic channels are formed on the major surface of a further substrate adapted and arranged to face a major surface of said first substrate, the further substrate being releasably secured to said first substrate.Type: ApplicationFiled: September 10, 2004Publication date: November 15, 2007Inventor: John Dodgson
-
Publication number: 20060228771Abstract: This invention relates to an apparatus for, and method of, making electrical measurements on objects, in particular cells, liposomes or similar small objects, in a medium. More particularly the invention relates to an apparatus for, and method of, making electrophysiological measurements on cells, liposomes or similar small objects, in a medium.Type: ApplicationFiled: November 9, 2005Publication date: October 12, 2006Inventors: John Dodgson, Lars Thomsen
-
Patent number: 6932893Abstract: The present invention relates to a high through-put system for determining and/or monitoring electrophysiological properties of ion channels of ion channel-containing membranes, typically lipid membrane-containing structures such as cells. In particular, the invention provides a substrate which provides means for automatically positioning cells at measuring sites using electroosmotic flow in canals formed on or in the substrate. The electroosmotic flow is generated and controlled by electroosmotic flow pumps integrated on the substrate or positioned in relation thereto. Thereby, cells can be positioned in favorable measurement configuration at a plurality of sites for performing testing and measurements. Also, the invention relates to a main electric circuit for performing testing and measurements on a plurality of cells in parallel.Type: GrantFiled: October 2, 2001Date of Patent: August 23, 2005Assignee: Sophion Bioscience A/SInventors: Morten Bech, Jørgen Due, Lars Thomsen, Jonatan Kutchinsky, Rafael Taboryski, Bent Erling Nielsen, John Shaw, John Dodgson
-
Patent number: 6846668Abstract: The microfabricated cell injector having an injection wall and a cell injection needle projecting from the wall for piercing cells suspended in a fluid. The needle is held within a housing defined by the internal surfaces of the microfabricated cell injector. The housing has an inlet for suspended cells to enter and an outlet for cells to exit via the cell injection needle. A cell propulsion device is provided for impelling cells towards the needle such that, in use, cells suspended in the fluid are impelled towards the injection wall by the injection needle.Type: GrantFiled: October 7, 1999Date of Patent: January 25, 2005Assignee: AstraZeneca ABInventors: Andrew J. Garman, David J. Scanlon, John Dodgson, John Ea Shaw, David Brennan, Anthony R. Corless, Christopher M. Turner
-
Publication number: 20040106189Abstract: The invention relates to an apparatus for and method of introducing a substance into an object, particularly into a cell or cellular material. In a preferred arrangement apparatus receives the cell and preferably locates it between first and second electrodes and applies a voltage pulse to cause a disruption in the cell wall. This causes the cell to become permeable. The substance may then be introduced, for example under a fluid pressure. Cells may then be inspected and sorted into transfected and non-transfected types. This may be achieved automatically, for example by using electrophoresis.Type: ApplicationFiled: November 10, 2003Publication date: June 3, 2004Applicant: AstraZeneca ABInventors: John Dodgson, Anthony R. Corless
-
Publication number: 20040020773Abstract: An apparatus and method for determining and/or monitoring electrophysiological properties of ion channels of ion-channel containing structures uses AC driven location electrodes to drive objects for analysis to a measurement site. The measurement site may comprise an aperture between two solution-containing compartments, each compartment containing a respective measurement electrode. The aperture includes an adhesion region at its periphery and is dimensioned so that the object for analysis cannot pass through the aperture. Alternatively, the measurement site may comprise a measurement electrode surrounded by an adhesion region appropriately dimensioned to receive the object, to which the object may adhere, and a second measurement electrode remote therefrom.Type: ApplicationFiled: June 19, 2002Publication date: February 5, 2004Inventors: Lars Thomsen, Dirk Reuter, John Dodgson, Anders Wolff, Jamil El-Ali
-
Patent number: 6653136Abstract: The invention relates to an apparatus for and method of introducing a substance into an object, particularly into a cell or cellular material. In a preferred arrangement apparatus receives the cell and preferably locates it between first and second electrodes and applies a voltage pulse to cause a disruption in the cell wall. This causes the cell to become permeable. The substance may then be introduced, for example under a fluid pressure. Cells may then be inspected and sorted into transfected and non-transfected types. This may be achieved automatically, for example by using electrophoresis.Type: GrantFiled: March 25, 2002Date of Patent: November 25, 2003Assignee: Astrazeneca ABInventors: John Dodgson, Anthony R Corless
-
Patent number: 6635160Abstract: The invention relates to gas sensors, particularly electrochemical gas sensors. The reliability of such gas sensors has been ascertained by regular tests, which involve exposing a sensor to a gas for test or calibration purposes. However, it has been difficult to provide a known quantity or concentration of gas. Another problem has been that blockage of a gas inlet has rendered the gas sensor unreliable. The invention provides a gas sensor having a self test capability and first and second electrodes, arranged so that test gas arrives at a separate instant at each electrode so as to generate two electric currents, the ratio of which currents provides an indication of the status of at least one electrode.Type: GrantFiled: December 28, 2001Date of Patent: October 21, 2003Assignee: Central Research Laboratories LimitedInventor: John Dodgson
-
Publication number: 20030121778Abstract: This invention relates to an apparatus for and method of making electrical measurements on cells, liposomes or similar small objects suspended in a medium. More particularly the invention relates to an apparatus and method for making electrophysiological measurements on cells.Type: ApplicationFiled: October 1, 2002Publication date: July 3, 2003Inventors: John Dodgson, Lars Thomsen
-
Publication number: 20030107386Abstract: This invention relates to an apparatus for, and method of, making electrical measurements on objects, in particular cells, liposomes or similar small objects, in a medium. More particularly the invention relates to an apparatus for, and method of, making electrophysiological measurements on cells, liposomes or similar small objects, in a medium.Type: ApplicationFiled: October 1, 2002Publication date: June 12, 2003Inventors: John Dodgson, Lars Thomsen
-
Patent number: 6454923Abstract: A gas sensor is described which is particularly well suited as a carbon monoxide (CO) sensor in a self test gas sensor. The sensor includes a number of aspects which may or may not be used in conjunction with one another. A first aspect is an embodiment which reduces electrical interference (or cross-talk) between a test or gas generating cell and a sensing cell. In one embodiment, baffles are provided to prevent cross-talk. In another embodiment a switching circuit ensures that a test gas generator is operational only when the gas sensor is disconnected from a current source. A second aspect is an embodiment which includes an improved wick which is in close proximity with an electrode and ensures electrolyte is always in contact with the electrode. In an alternate embodiment a solid polymer electrolyte is used between the electrodes. A third aspect is an improved catalyst which reduces the reaction energy and thereby renders the sensor more sensitive. The catalyst is also cheaper than platinum.Type: GrantFiled: June 23, 2000Date of Patent: September 24, 2002Assignee: Central Research Laboratories LimitedInventors: John Dodgson, John Edward Andrew Shaw, Malcolm Austen, Monica Backes
-
Publication number: 20020063067Abstract: The present invention relates to a high through-put system for determining and/or monitoring electrophysiological properties of ion channels of ion channel-containing membranes, typically lipid membrane-containing structures such as cells. In particular, the invention provides a substrate which provides means for automatically positioning cells at measuring sites using electroosmotic flow in canals formed on or in the substrate. The electroosmotic flow is generated and controlled by electroosmotic flow pumps integrated on the substrate or positioned in relation thereto. Thereby, cells can be positioned in favorable measurement configuration at a plurality of sites for performing testing and measurements. Also, the invention relates to a main electric circuit for performing testing and measurements on a plurality of cells in parallel.Type: ApplicationFiled: October 2, 2001Publication date: May 30, 2002Inventors: Morten Bech, Jorgen Due, Lars Thomsen, Jonatan Kutchinsky, Rafael Taboryski, Bent Erling Nielsen, John Shaw, John Dodgson